SlideShare a Scribd company logo
Julien Beauté, ECDC
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Evaluation of severe influenza
surveillance in Europe
Background
• 2009 influenza pandemic
− First attempt to monitor severe cases at EU level
− Rapid development of surveillance – July 2009
• 2010-to the present date
− Six to ten EU/EEA countries reporting (seven for the
2013/14 season)
− Thirteen countries reported SARI data to EuroFlu for
the 2013/14 season (including two EU countries)
− Cases admitted to intensive care units or any ward
− Sentinel or comprehensive surveillance
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Outputs
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
• Weekly influenza bulletins
• ECDC seasonal risk assessment
• Annual reports
• Peer-reviewed publications
Evaluation of severe influenza surveillance
• To provide ECDC with:
− Clear statement on epidemiological and public health
usefulness
− Future scenarios and recommendations
• Requested deliverables:
− Description of the surveillance of severe influenza in
all the EU/EEA states
− Review of the surveillance at the EU/EEA level
− Comparison with systems elsewhere
− Guidance for future
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Evaluation of severe influenza surveillance
• Findings:
− Heterogeneity of systems in
place hinders any significant
added value from an European
perspective
− Example of federally organised
countries (e.g. U.S.) strongly
argues in favour of more
harmonised systems
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Key features of severe influenza
surveillance systems in EU/EEA countries
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
37th ECDC Advisory Forum, 27 Feb 2014
• Options
− Abandon severe influenza surveillance
− Proceed with the current strategy aiming at
improving harmonisation and increasing the number
of participating countries
− Proceed with the current system, but restrict severe
influenza surveillance to intensive care units
− Establish a new surveillance system based on a
European network of sentinel hospitals
− …
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014
Recommendations
• 37th ECDC Advisory Forum, 27 Feb 2014
– Proceed with the current system, but restrict severe
influenza surveillance to intensive care units
– Clarify the objectives of severe influenza surveillance
at the European level
• EISN Coordination Committee meeting, 19 Mar 2014
– Convince countries collecting data to participate
– Agree on denominator data
– Explore alternative monitoring systems
– Estimate risk factors for severe disease
Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting
Vienna, 11-13 June 2014

More Related Content

What's hot

Cross sectional study-dr.wah
Cross sectional study-dr.wahCross sectional study-dr.wah
Cross sectional study-dr.wah
Mmedsc Hahm
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiologymlogaraj
 
IDSP.pptx
IDSP.pptxIDSP.pptx
IDSP.pptx
anjalatchi
 
Emerging & re emerging infections
Emerging & re emerging infectionsEmerging & re emerging infections
Emerging & re emerging infections
swati shikha
 
Vaccination faliure
Vaccination faliureVaccination faliure
Vaccination faliure
Ossama Motawae
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
Dalia El-Shafei
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studiesBruno Mmassy
 
Randomized Controlled Trial
Randomized Controlled Trial Randomized Controlled Trial
Randomized Controlled Trial
Sumit Das
 
Influenza
InfluenzaInfluenza
Influenza
thegowda
 
Presentation1 resom 12
Presentation1 resom 12Presentation1 resom 12
Presentation1 resom 12Resomtsegay
 
Sample size
Sample sizeSample size
Sample sizezubis
 
Health financing strategies uhc 27 09 12
Health financing strategies   uhc 27 09 12Health financing strategies   uhc 27 09 12
Health financing strategies uhc 27 09 12
Vikash Keshri
 
EPI Schedule and diseases.pptx
EPI Schedule and diseases.pptxEPI Schedule and diseases.pptx
EPI Schedule and diseases.pptx
Zaid Azhar
 
Control and prevention_of_influenza
Control and prevention_of_influenzaControl and prevention_of_influenza
Control and prevention_of_influenzaChandan N
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1Rizwan S A
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillanceDr.RAJEEV KASHYAP
 

What's hot (20)

Cross sectional study-dr.wah
Cross sectional study-dr.wahCross sectional study-dr.wah
Cross sectional study-dr.wah
 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
 
IDSP.pptx
IDSP.pptxIDSP.pptx
IDSP.pptx
 
Cholera
CholeraCholera
Cholera
 
public health surveillance
public health surveillance public health surveillance
public health surveillance
 
Emerging & re emerging infections
Emerging & re emerging infectionsEmerging & re emerging infections
Emerging & re emerging infections
 
Vaccination faliure
Vaccination faliureVaccination faliure
Vaccination faliure
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
 
Epidemiological studies
Epidemiological studiesEpidemiological studies
Epidemiological studies
 
Randomized Controlled Trial
Randomized Controlled Trial Randomized Controlled Trial
Randomized Controlled Trial
 
Influenza
InfluenzaInfluenza
Influenza
 
Presentation1 resom 12
Presentation1 resom 12Presentation1 resom 12
Presentation1 resom 12
 
Outbreak Investigation
Outbreak InvestigationOutbreak Investigation
Outbreak Investigation
 
Sample size
Sample sizeSample size
Sample size
 
Health financing strategies uhc 27 09 12
Health financing strategies   uhc 27 09 12Health financing strategies   uhc 27 09 12
Health financing strategies uhc 27 09 12
 
EPI Schedule and diseases.pptx
EPI Schedule and diseases.pptxEPI Schedule and diseases.pptx
EPI Schedule and diseases.pptx
 
Control and prevention_of_influenza
Control and prevention_of_influenzaControl and prevention_of_influenza
Control and prevention_of_influenza
 
Incidence And Prevalence
Incidence And PrevalenceIncidence And Prevalence
Incidence And Prevalence
 
Case control study – part 1
Case control study – part 1Case control study – part 1
Case control study – part 1
 
A basic understanding of HIV surveillance
A basic understanding of HIV surveillanceA basic understanding of HIV surveillance
A basic understanding of HIV surveillance
 

Similar to Evaluation of severe influenza surveillance in europe

Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
European Centre for Disease Prevention and Control
 
Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...
WHO Regional Office for Europe
 
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
European Centre for Disease Prevention and Control
 
Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...
THL
 
Antiviral treatment policy
Antiviral treatment policyAntiviral treatment policy
Options for RSV surveillance in Europe
Options for RSV surveillance in EuropeOptions for RSV surveillance in Europe
Options for RSV surveillance in Europe
European Center for Disease Prevention and Control (ECDC)
 
Pete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-PortfolioPete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-PortfolioPete Kinross
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
European Centre for Disease Prevention and Control
 
Eu lab cap update
Eu lab cap updateEu lab cap update
ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness
European Center for Disease Prevention and Control (ECDC)
 
WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
European Centre for Disease Prevention and Control (ECDC)
 
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCInfluenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
DRIVE research
 
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
WHO Regional Office for Europe
 
Avian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdcAvian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdc
Cornelia Adlhoch
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
European Centre for Disease Prevention and Control
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
European Centre for Disease Prevention and Control
 
Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)
WHO Regional Office for Europe
 
CBA on reference laboratories human pathogens
CBA on reference laboratories human pathogensCBA on reference laboratories human pathogens
CBA on reference laboratories human pathogens
European Center for Disease Prevention and Control (ECDC)
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
European Centre for Disease Prevention and Control (ECDC)
 

Similar to Evaluation of severe influenza surveillance in europe (20)

Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
Recurring hepatitis A outbreaks in the EU/EEA: summary of the recommendations...
 
Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...Implementation of the International Health Regulations (2005) in the WHO Euro...
Implementation of the International Health Regulations (2005) in the WHO Euro...
 
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
ECDC ARHAI networks: achievements in 2013-2014 and challenges for 2015-2016, ...
 
Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...Persistent differences in health outcomes for major medical conditions across...
Persistent differences in health outcomes for major medical conditions across...
 
Antiviral treatment policy
Antiviral treatment policyAntiviral treatment policy
Antiviral treatment policy
 
Options for RSV surveillance in Europe
Options for RSV surveillance in EuropeOptions for RSV surveillance in Europe
Options for RSV surveillance in Europe
 
Pete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-PortfolioPete-Kinross-EPIET-Fellowship-Portfolio
Pete-Kinross-EPIET-Fellowship-Portfolio
 
Monitoring the EU’s response to the HIV epidemic
Monitoring the EU’s response to  the HIV epidemicMonitoring the EU’s response to  the HIV epidemic
Monitoring the EU’s response to the HIV epidemic
 
Eu lab cap update
Eu lab cap updateEu lab cap update
Eu lab cap update
 
Session 25 andrzej_rys
Session 25 andrzej_rysSession 25 andrzej_rys
Session 25 andrzej_rys
 
ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness ECDC and WHO collaborative activities to improve laboratory preparedness
ECDC and WHO collaborative activities to improve laboratory preparedness
 
WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)WHO Global Action Plan. Charles Penn (WHO)
WHO Global Action Plan. Charles Penn (WHO)
 
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDCInfluenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
Influenza vaccine effectiveness studies in Europe - Pasi Penttinen ECDC
 
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
First World Antibiotic Awareness Week and awareness campaigns on prudent anti...
 
Avian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdcAvian influenza workshop 2015_ecdc
Avian influenza workshop 2015_ecdc
 
PrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overviewPrEP implementation strategies across Europe – an overview
PrEP implementation strategies across Europe – an overview
 
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
From Dublin to Rome: 10 years of the HIV epidemic and response in Europe
 
Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)Global action plan to combat antimicrobial resistance (AMR)
Global action plan to combat antimicrobial resistance (AMR)
 
CBA on reference laboratories human pathogens
CBA on reference laboratories human pathogensCBA on reference laboratories human pathogens
CBA on reference laboratories human pathogens
 
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
WHO/Europe priorities and activities. Danilo Lo Fo Wong (WHO/Europe)
 

More from European Centre for Disease Prevention and Control

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
European Centre for Disease Prevention and Control
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
European Centre for Disease Prevention and Control
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
European Centre for Disease Prevention and Control
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
European Centre for Disease Prevention and Control
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
European Centre for Disease Prevention and Control
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
European Centre for Disease Prevention and Control
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
European Centre for Disease Prevention and Control
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
European Centre for Disease Prevention and Control
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
European Centre for Disease Prevention and Control
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
European Centre for Disease Prevention and Control
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
European Centre for Disease Prevention and Control
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
European Centre for Disease Prevention and Control
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
European Centre for Disease Prevention and Control
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
European Centre for Disease Prevention and Control
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
European Centre for Disease Prevention and Control
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
European Centre for Disease Prevention and Control
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
European Centre for Disease Prevention and Control
 

More from European Centre for Disease Prevention and Control (20)

Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019Tuberculosis situation in the EU/EEA, 2019
Tuberculosis situation in the EU/EEA, 2019
 
Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018Tuberculosis situation in the EU/EEA, 2018
Tuberculosis situation in the EU/EEA, 2018
 
HIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 dataHIV AIDS surveillance in Europe 2019- 2018 data
HIV AIDS surveillance in Europe 2019- 2018 data
 
Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)Status of PrEP implementation in Europe (Nov 2019)
Status of PrEP implementation in Europe (Nov 2019)
 
90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action90-90-90 Goals in Europe: In Action
90-90-90 Goals in Europe: In Action
 
The public health response to increasing syphilis trends in Europe
The public health response to increasing  syphilis trends in EuropeThe public health response to increasing  syphilis trends in Europe
The public health response to increasing syphilis trends in Europe
 
Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017Tuberculosis situation in the EU/EEA, 2017
Tuberculosis situation in the EU/EEA, 2017
 
Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States Situation overview on hepatitis E in the EU/EEA Member States
Situation overview on hepatitis E in the EU/EEA Member States
 
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted DiseasesAnnual Epidemiological Report for 2017: Sexually Transmitted Diseases
Annual Epidemiological Report for 2017: Sexually Transmitted Diseases
 
The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...The attributable fraction of deaths due to viral hepatitis: results from a se...
The attributable fraction of deaths due to viral hepatitis: results from a se...
 
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 dataSurveillance of hepatitis B and C in the EU/EEA – 2017 data
Surveillance of hepatitis B and C in the EU/EEA – 2017 data
 
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak InvestigationWhole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
Whole Genome Sequencing in EU Multi-country Foodborne Outbreak Investigation
 
Respondent Driven Sampling
Respondent Driven Sampling Respondent Driven Sampling
Respondent Driven Sampling
 
Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)Online Respondent-Driven Detection (RDD)
Online Respondent-Driven Detection (RDD)
 
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
What have we overlooked in the epidemiology of antimicrobial resistance in Eu...
 
HIV/AIDS surveillance in Europe 2018 (2017 data)
HIV/AIDS surveillance in Europe  2018 (2017 data)HIV/AIDS surveillance in Europe  2018 (2017 data)
HIV/AIDS surveillance in Europe 2018 (2017 data)
 
Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?Infections among people who inject drugs -- problem solved?
Infections among people who inject drugs -- problem solved?
 
Strategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in EuropeStrategies to reduce HIV incidence in Europe
Strategies to reduce HIV incidence in Europe
 
Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016 Sexually transmitted infections, EU/EEA, 2016
Sexually transmitted infections, EU/EEA, 2016
 
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 dataTuberculosis situation in the EU/EEA, 2018 - 2016 data
Tuberculosis situation in the EU/EEA, 2018 - 2016 data
 

Recently uploaded

Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
MGM SCHOOL/COLLEGE OF NURSING
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
BrissaOrtiz3
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
SwisschemDerma
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Bright Chipili
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 

Recently uploaded (20)

Identification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptxIdentification and nursing management of congenital malformations .pptx
Identification and nursing management of congenital malformations .pptx
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Netter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdfNetter's Atlas of Human Anatomy 7.ed.pdf
Netter's Atlas of Human Anatomy 7.ed.pdf
 
Top-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India ListTop-Vitamin-Supplement-Brands-in-India List
Top-Vitamin-Supplement-Brands-in-India List
 
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptxSURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 

Evaluation of severe influenza surveillance in europe

  • 1. Julien Beauté, ECDC Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014 Evaluation of severe influenza surveillance in Europe
  • 2. Background • 2009 influenza pandemic − First attempt to monitor severe cases at EU level − Rapid development of surveillance – July 2009 • 2010-to the present date − Six to ten EU/EEA countries reporting (seven for the 2013/14 season) − Thirteen countries reported SARI data to EuroFlu for the 2013/14 season (including two EU countries) − Cases admitted to intensive care units or any ward − Sentinel or comprehensive surveillance Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 3. Outputs Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014 • Weekly influenza bulletins • ECDC seasonal risk assessment • Annual reports • Peer-reviewed publications
  • 4. Evaluation of severe influenza surveillance • To provide ECDC with: − Clear statement on epidemiological and public health usefulness − Future scenarios and recommendations • Requested deliverables: − Description of the surveillance of severe influenza in all the EU/EEA states − Review of the surveillance at the EU/EEA level − Comparison with systems elsewhere − Guidance for future Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 5. Evaluation of severe influenza surveillance • Findings: − Heterogeneity of systems in place hinders any significant added value from an European perspective − Example of federally organised countries (e.g. U.S.) strongly argues in favour of more harmonised systems Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 6. Key features of severe influenza surveillance systems in EU/EEA countries Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 7. 37th ECDC Advisory Forum, 27 Feb 2014 • Options − Abandon severe influenza surveillance − Proceed with the current strategy aiming at improving harmonisation and increasing the number of participating countries − Proceed with the current system, but restrict severe influenza surveillance to intensive care units − Establish a new surveillance system based on a European network of sentinel hospitals − … Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014
  • 8. Recommendations • 37th ECDC Advisory Forum, 27 Feb 2014 – Proceed with the current system, but restrict severe influenza surveillance to intensive care units – Clarify the objectives of severe influenza surveillance at the European level • EISN Coordination Committee meeting, 19 Mar 2014 – Convince countries collecting data to participate – Agree on denominator data – Explore alternative monitoring systems – Estimate risk factors for severe disease Joint WHO/Europe & ECDC Annual Influenza Surveillance Meeting Vienna, 11-13 June 2014